Literature DB >> 7610759

Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease.

P Cras1, M A Smith, P L Richey, S L Siedlak, P Mulvihill, G Perry.   

Abstract

In this report we quantitatively assess the numbers of intracellular and extracellular neurofibrillary tangles (NFT) in the brains of a series of individuals with Alzheimer's disease and of controls and correlate these with neuronal loss. Our data indicate that in some cases, NFT are not removed from the brain throughout the disease process. This finding, together with our previous demonstration of carbonyl-related modifications in NFT, provides additional evidence that the protein constituents of NFT are resistant to proteolytic removal, possibly as a result of extensive cross-links. Additionally, correlation between the number of NFT and neuronal loss indicates that there are at least two distinct mechanisms responsible for neuronal death in Alzheimer's disease that are directly and indirectly related to the presence of neurofibrillary pathology.

Entities:  

Mesh:

Year:  1995        PMID: 7610759     DOI: 10.1007/BF00309621

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  25 in total

1.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

Authors:  I Grundke-Iqbal; K Iqbal; Y C Tung; M Quinlan; H M Wisniewski; L I Binder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

2.  An ultrastructural analysis of the effects of accumulation of neurofibrillary tangle in pyramidal neurons of the cerebral cortex in Alzheimer's disease.

Authors:  P Q Sumpter; D M Mann; C A Davies; P O Yates; J S Snowden; D Neary
Journal:  Neuropathol Appl Neurobiol       Date:  1986 May-Jun       Impact factor: 8.090

3.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

4.  Neurofibrillary tangles of Alzheimer's disease: an immunohistochemical study.

Authors:  J P Brion; A M Couck; E Passareiro; J Flament-Durand
Journal:  J Submicrosc Cytol       Date:  1985-01

Review 5.  Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease.

Authors:  M A Smith; P L Richey; S Taneda; R K Kutty; L M Sayre; V M Monnier; G Perry
Journal:  Ann N Y Acad Sci       Date:  1994-11-17       Impact factor: 5.691

6.  Alzheimer disease: an imbalance of proteolytic regulation?

Authors:  M A Smith; G Perry
Journal:  Med Hypotheses       Date:  1994-04       Impact factor: 1.538

7.  Correlation between senile plaque and neurofibrillary tangle counts in cerebral cortex and neuronal counts in cortex and subcortical structures in Alzheimer's disease.

Authors:  D M Mann; P O Yates; B Marcyniuk
Journal:  Neurosci Lett       Date:  1985-05-01       Impact factor: 3.046

8.  Basic fibroblast growth factor binding is a marker for extracellular neurofibrillary tangles in Alzheimer disease.

Authors:  S L Siedlak; P Cras; M Kawai; P Richey; G Perry
Journal:  J Histochem Cytochem       Date:  1991-07       Impact factor: 2.479

9.  On areas of transition between entorhinal allocortex and temporal isocortex in the human brain. Normal morphology and lamina-specific pathology in Alzheimer's disease.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

10.  The progression of the pathological changes of Alzheimer's disease in frontal and temporal neocortex examined both at biopsy and at autopsy.

Authors:  D M Mann; B Marcyniuk; P O Yates; D Neary; J S Snowden
Journal:  Neuropathol Appl Neurobiol       Date:  1988 May-Jun       Impact factor: 8.090

View more
  26 in total

Review 1.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Authors:  M Goedert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Alzheimer disease: caspases first.

Authors:  Jesús Avila
Journal:  Nat Rev Neurol       Date:  2010-11       Impact factor: 42.937

Review 3.  The tauopathies: toward an experimental animal model.

Authors:  M Goedert; M Hasegawa
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

Review 4.  Deregulated Cdk5 activity is involved in inducing Alzheimer's disease.

Authors:  Varsha Shukla; Susan Skuntz; Harish C Pant
Journal:  Arch Med Res       Date:  2012-11-07       Impact factor: 2.235

5.  Resveratrol Induces Brain Resilience Against Alzheimer Neurodegeneration Through Proteostasis Enhancement.

Authors:  Rubén Corpas; Christian Griñán-Ferré; Eduard Rodríguez-Farré; Mercè Pallàs; Coral Sanfeliu
Journal:  Mol Neurobiol       Date:  2018-06-13       Impact factor: 5.590

6.  Detection and localization of markers of oxidative stress by in situ methods: application in the study of Alzheimer disease.

Authors:  Paula I Moreira; Lawrence M Sayre; Xiongwei Zhu; Akihiko Nunomura; Mark A Smith; George Perry
Journal:  Methods Mol Biol       Date:  2010

Review 7.  Antioxidant therapy in Alzheimer's disease: theory and practice.

Authors:  Gjumrakch Aliev; Mark E Obrenovich; V Prakash Reddy; Justin C Shenk; Paula I Moreira; Akihiko Nunomura; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  Mini Rev Med Chem       Date:  2008-11       Impact factor: 3.862

8.  Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease.

Authors:  Miranda L Bader Lange; Giovanna Cenini; Marta Piroddi; Hafiz Mohmmad Abdul; Rukhsana Sultana; Francesco Galli; Maurizio Memo; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2007-11-12       Impact factor: 5.996

9.  Accumulation of aspartic acid421- and glutamic acid391-cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease.

Authors:  Gustavo Basurto-Islas; Jose Luna-Muñoz; Angela L Guillozet-Bongaarts; Lester I Binder; Raul Mena; Francisco García-Sierra
Journal:  J Neuropathol Exp Neurol       Date:  2008-05       Impact factor: 3.685

10.  Inhibition of tau polymerization with a cyanine dye in two distinct model systems.

Authors:  Erin E Congdon; Yvette H Figueroa; Lili Wang; Galina Toneva; Edward Chang; Jeff Kuret; Christopher Conrad; Karen E Duff
Journal:  J Biol Chem       Date:  2009-05-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.